KIMSHEALTH performs two allogeneic stem cell transplants, one a complex half-match procedure
Allogeneic stem cell transplant involves replacing diseased stem cells in the bone marrow with healthy ones from a donor.
In haploidentical or half-match transplants, the recipient shares only a partial genetic match with the donor, who is usually a family member.
The half-match transplant was performed on a 37-year-old woman diagnosed with acute myeloid leukemia (AML). Although her sister was the donor, their incompatible blood groups made the procedure particularly complex.
To further compound the challenge, the patient was also battling multi-drug resistant bacterial infections and aspergillosis — a fungal infection that typically affects immunocompromised individuals.
After the transplant, she contracted cytomegalovirus (CMV), a viral infection, for which she was treated with antivirals. Despite these life-threatening complications, the patient made a full recovery. A bone marrow assessment conducted 100 days after the transplant confirmed that she was disease-free.
The second successful transplant involved a 63-year-old male patient, also diagnosed with AML, who underwent an allogeneic transplant from a fully matched sibling donor.
Despite the age- related risks and potential complications involved, the patient showed remarkable progress and is in remission as of day 100 post-transplant., the press release said.
'Haploidentical transplants, especially in cases where blood groups are incompatible, demand an advanced skill set and precision,' it said.
The treatment was led by Bijay P Nair, Senior Consultant , Department of Clinical Hematology and Bone Marrow Transplant . The team Included K. S. Lekshmon and Aswin V. Nair, Associate Consultants and Sanooja Pinki, Department of Transfusion Medicine, KIMSHEALTH.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
22-07-2025
- Time of India
Leukemia risk higher for children living near oil and gas wells, finds study
Leukemia, a type of cancer that affects the blood and bone marrow and is characterized by the rapid production of abnormal white blood cells, is projected to have 66,890 new cases and 23,540 deaths in 2025, representing 3.3% of all new cancer cases and 3.8% of all cancer deaths worldwide . In leukemia, the abnormal cells, called blasts or leukemia cells, are not fully developed and cannot effectively fight infection. This leads to a decline in healthy blood cells, including red blood cells and platelets, and can cause various symptoms. While the incidence of leukemia is rising, mortality rates are declining due to advancements in treatment. Leukemia, particularly acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), continues to be a significant global health concern with variations in burden across different regions and socioeconomic levels. And now, a new study has revealed that children residing near oil and natural gas wells face a substantially higher risk of developing a rare form of childhood cancer. Read on to know more. A tale of two studies Using a case‑control design comparing 451 children diagnosed with ALL to over 2,700 controls, Colorado researchers found that children aged 2–9 living within 3–8 miles of active wells were at least twice as likely to develop ALL. In high-intensity drilling zones, the risk doubled again. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Why Crypto CFDs May Suit Your Portfolio IC Markets Learn More Undo In Pennsylvania, a similar study covering 405 ALL cases found that living within 1.2 miles of a well at birth correlated with a two‑to‑three‑times higher risk by ages 2–7. Let's delve deeper into the two defining studies. Colorado study Researchers in Colorado analyzed 451 ALL cases from 2002–2021 and compared them with 2,700 cancer-free peers using precise mapping techniques that measured both proximity to wells and drilling activity intensity. Children living within 5 km of high-intensity sites had double the risk (OR=2.00) of developing ALL. Even within 13 km, the risk rose by 40–164%, depending on well activity levels. These results highlight a dose-response relationship; closer or denser well activity corresponds to higher leukemia risk. Pennsylvania study In Pennsylvania , 405 ALL cases diagnosed between 2009–2017 were compared to 2,080 controls. Children born within 1.2 miles (2 km) of oil and gas wells faced a two to three times greater risk of leukemia by age 7 compared to those born farther away. The risk was notably elevated when mothers lived near wells during pregnancy, which emphasized a critical window of vulnerability. The risk factor Oil and gas wells emit leukemogenic chemicals, notably benzene, formaldehyde, 1,3-butadiene, and polycyclic aromatic hydrocarbons (PAHs), through venting, flaring, diesel traffic, and wastewater operations. Benzene, as research has already shown, is a well-known blood cancer agent, accounting for nearly 95% of cancer risk estimates within 150 m of wells. These pollutants can infiltrate air, soil, and water, potentially damaging children's bone marrow during sensitive developmental periods. What to do then? Current regulatory "setbacks" in the US vary widely, from 200 ft to 3,200 ft (≈1 km), but the new data suggests these distances may be insufficient. In Colorado, children within 13 km still exhibited elevated leukemia risk. After this concerning data-driven research, researchers urge the implementation of more protective buffer zones around sensitive locations like homes, schools, and playgrounds. They also put an emphasis to check for air quality and emission standards for existing and new wells, and recommend incorporation of cumulative exposure considerations in permitting decisions. Scope for the future Despite robust findings from the research, studies cannot establish causality or quantify the exact chemical exposure. McKenzie cautions that researchers did not measure individual benzene concentrations; rather, they deduced the risk based on proximity and drilling intensity. As the researchers suggest, future research should expand to high-drilling states like Texas and California, examine links between exposure and other pediatric cancers (e.g., acute myeloid leukemia, lymphoma), and assess long-term health outcomes beyond ALL. Study finds living near oil, gas wells increases air pollution exposure
News18
15-07-2025
- News18
Advanced Procedure Gives New Lease Of Life To 47-Year-Old Who Suffered Repeated Cardiac Arrests
The patient underwent multiple emergency defibrillations due to ventricular fibrillation, a life-threatening heart rhythm disorder, and experienced repeated cardiac arrests An advanced procedure by the medical team at KIMSHEALTH saved a 47-year-old man who had developed severe heart complications. The patient was initially admitted to a nearby hospital and placed on a ventilator after collapsing at his workplace. He was then referred to KIMSHEALTH for advanced cardiac care. He underwent multiple emergency defibrillations due to ventricular fibrillation, a life-threatening heart rhythm disorder, and experienced repeated cardiac arrests. Despite having no prior history of heart disease, cardiac imaging revealed that his heart muscle function had deteriorated due to an unknown cause. While in the ICU, the patient suffered repeated episodes of rhythm disorder, and his blood pressure dropped to undetectable levels. He was immediately placed on ECMO (Extracorporeal Membrane Oxygenation) to stabilise his heart and lungs. As the support was weaned, he once again developed fibrillation. At this critical juncture, the medical team led by Dr. Anees Thajudeen, Senior Consultant, Department of Cardiology and Electrophysiology, opted for an advanced and relatively new life-saving intervention: mapping and ablation of ventricular tachycardia (VT). A specialised catheter was inserted through the groin into the heart's main pumping chamber and mapped in real-time. Much like a GPS tracking system, the catheter recorded electrical signals and identified scarred areas responsible for generating these dangerous rhythms. These areas were then precisely targeted and ablated to eliminate the arrhythmia. During the procedure, the patient had to be defibrillated four times. However, by the end of the successful intervention, all dangerous arrhythmias were eliminated. After confirming that he was free of abnormal rhythms, an implantable defibrillator was inserted to protect against any future arrhythmias. Following the procedure, the patient made an extraordinary recovery. The repeated cardiac arrests had taken a toll on the function of other organs, including the kidneys and liver. However, with the rhythm problem resolved, the patient made slow and steady progress. Dialysis was gradually withdrawn, and he was discharged after a six-week hospital stay. 'Immediate resuscitation from cardiac arrest is a skill most doctors are trained for. But for high-risk patients like this, a dedicated team of critical care experts is required to stabilize and maintain vital organ functions in the initial days. This allows complex procedures like the ablation of ventricular tachycardia to be performed safely and effectively, resulting in a long-term cure," said Dr Anees Thajudeen. Dr Shaji Palangadan, Senior Consultant, Department of Cardio-Thoracic Surgery; Dr Satish B, Senior Consultant, Department of Nephrology; Dr Subash S and Dr. Anil Radhakrishnan Pillai, Consultants, Department of Cardiac Anaesthesia, were also part of the treatment team. view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Hans India
29-06-2025
- Hans India
Deadly blood cancer can now be detected early with blood test: Study
A team of Israeli and American scientists have developed a groundbreaking blood test that may soon revolutionize the early detection of leukaemia and other blood-related disorders. The test, which analyzes a simple blood sample, could eliminate the need for invasive bone marrow biopsies currently used in diagnosis. Published in the prestigious journal Nature Medicine, the study was led by researchers from the Weizmann Institute of Science in Israel. The team focused their work on identifying early indicators of myelodysplastic syndrome (MDS), an age-related condition in which blood-forming stem cells fail to develop correctly. MDS is particularly dangerous as it can lead to severe anaemia and progress into acute myeloid leukaemia (AML), a fast-growing type of blood cancer prevalent among adults. Currently, diagnosing MDS requires a painful and intrusive procedure — bone marrow sampling — which involves drilling into the pelvic bone under local anaesthesia. For many patients, especially older adults, this process is uncomfortable and distressing. The new research offers a promising alternative. The scientists discovered that rare blood-forming stem cells, which occasionally escape from the bone marrow and circulate in the bloodstream, carry crucial genetic clues about the early development of MDS. Using advanced single-cell genetic sequencing techniques, the researchers successfully decoded the information contained within these rare cells — all from a routine blood draw. One of the most remarkable findings was that these circulating stem cells not only provide early markers of disease but also appear to act as biological 'clocks' that reflect a person's chronological aging. 'These stem cells give us insights not only into early-stage disease but also into how aging progresses differently in men and women,' explained Dr. Nili Furer of the Weizmann Institute. 'We found that in males, the changes in these cells occur earlier than in females, potentially explaining the higher incidence of blood cancers among men.' The study holds significant promise for the future of cancer diagnostics. By replacing an uncomfortable and invasive procedure with a simple blood test, early detection becomes more accessible and patient-friendly. Furthermore, the researchers believe this breakthrough method could be adapted to detect other age-related blood disorders beyond MDS and AML. A large-scale international clinical trial is already underway to validate the effectiveness of the blood test across multiple medical centers worldwide. If successful, this new method could pave the way for more accurate, less invasive, and earlier diagnoses of life-threatening blood cancers, ultimately improving outcomes and quality of life for countless patients.
